Therapeutic Goods (Standard for Psilocybine) (TGO 113) Order 2024

The Therapeutic Goods (Standard for Psilocybine) (TGO 113) Order 2024 establishes new quality standards for psilocybine products in Australia.

Official version of legislation
The Federal Register of Legislation is the authorised Australian Government website for Commonwealth legislation. It contains the full text and details of the life cycle of individual laws.

The Therapeutic Goods (Standard for Psilocybine) (TGO 113) Order 2024 establishes new quality standards for psilocybine products in Australia.

These standards specify the minimum quality requirements for both the active pharmaceutical ingredient (API) and finished products.

Read the legislation

Guidance referring to this legislation

Complying with the quality requirements for MDMA and psilocybine

29 October 2024

Guidance

Guidance on how to comply with the quality standards for MDMA (TGO 112) and psilocybine (TGO 113).

Product types

MDMA and psilocybine